Literature DB >> 23677464

CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway.

Zhubo Chen1, Yanmei Han, Yan Gu, Yanfang Liu, Zhengping Jiang, Minghui Zhang, Xuetao Cao.   

Abstract

Regulatory T cells can restrict the uncontrolled immune response and inflammation, avoiding pathologic immune injury to the host and thus playing important roles in the maintenance of immune homeostasis. Until recently, many subsets of CD4 and CD8 regulatory T cells have been reported. In this study, we identified CD11c(high)CD8(+) T cells as a new subset of CD8(+) regulatory T cells. During Listeria monocytogenes and Staphylococcus aureus infection, two subsets of CD8 T cells were classified according to the expression level of CD11c, including CD11c(low)CD8(+) and CD11c(high)CD8(+) T cells. CD11c(low)CD8(+) T cells, existing during the whole period of infection, act as conventional activated T cells to kill target cells in a perforin-dependent manner. Interestingly, CD11c(high)CD8(+) T cells appeared only at a late stage of infection, expressed relatively high CD122 and low CD69, did not secrete IFN-γ, IL-10, TGF-β, and exhibited much more potent cytotoxicity against target cells via Fas ligand-Fas pathway in an Ag-independent manner. Ligation of CD11c was important in the cytotoxicity of CD11c(high)CD8(+) T cells. Furthermore, CD11c(high)CD8(+) T cells could directly kill the activated CD4 T cells both in vitro and in vivo, whereas CD11c(low)CD8(+) T cells could not. Thus, we identified an infection-induced new subset of CD11c(high)CD8(+) regulatory T cells, which might contribute to protect host from pathological immune injure. Our results indicate that CD11c(+)CD8(+) T cells are constitute a heterogeneous population that can be divided further into regulatory CD11c(high)CD8(+) T cell subset and effector CD11c(low)CD8(+) T cell subset, thus adding insight to the role of CD8 T cells in immune response and regulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677464     DOI: 10.4049/jimmunol.1300060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity.

Authors:  Kazuyuki Akane; Seiji Kojima; Tak W Mak; Hiroshi Shiku; Haruhiko Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

Review 2.  Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy.

Authors:  Shuping Zhang; Meng Wu; Fang Wang
Journal:  Cell Mol Immunol       Date:  2018-09       Impact factor: 11.530

Review 3.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

4.  Gene expression profiling of CD8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8+ Treg cell production.

Authors:  Meng Wu; Jianfang Lou; Shuping Zhang; Xian Chen; Lei Huang; Ruihong Sun; Peijun Huang; Shiyang Pan; Fang Wang
Journal:  Cell Prolif       Date:  2016-09-19       Impact factor: 6.831

Review 5.  Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.

Authors:  Ann J Ligocki; Jerry Y Niederkorn
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

6.  CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability.

Authors:  Stoyan Ivanov; Joshua P Scallan; Ki-Wook Kim; Kathrin Werth; Michael W Johnson; Brian T Saunders; Peter L Wang; Emma L Kuan; Adam C Straub; Melissa Ouhachi; Erica G Weinstein; Jesse W Williams; Carlos Briseño; Marco Colonna; Brant E Isakson; Emmanuel L Gautier; Reinhold Förster; Michael J Davis; Bernd H Zinselmeyer; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

7.  Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.

Authors:  Yanmei Han; Yuan Yang; Zhubo Chen; Zhengping Jiang; Yan Gu; Yanfang Liu; Sheng Xu; Chuan Lin; Zeya Pan; Weiping Zhou; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2014-03-26       Impact factor: 4.599

Review 8.  Polymeric micro- and nanoparticles for immune modulation.

Authors:  Elana Ben-Akiva; Savannah Est Witte; Randall A Meyer; Kelly R Rhodes; Jordan J Green
Journal:  Biomater Sci       Date:  2018-12-18       Impact factor: 6.843

Review 9.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

10.  Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential.

Authors:  Jamal Qualai; Lin-Xi Li; Jon Cantero; Antoni Tarrats; Marco Antonio Fernández; Lauro Sumoy; Annie Rodolosse; Stephen J McSorley; Meritxell Genescà
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.